中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）

2019-06-02 国家药品监督管理局药品审评中心（CDE） CDE

中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）

中文标题：

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2019-06-02

简要介绍：

中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=29ee51c001986e24, title=中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）, enTitle=, guiderFrom=CDE, authorId=0, author=, summary=中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）, cover=, journalId=0, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Sun Jun 02 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<p>中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）</p>, tagList=[TagDto(tagId=26642, tagName=指导原则)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2860, appHits=144, showAppHits=0, pcHits=530, showPcHits=2716, likes=1, shares=12, comments=8, approvalStatus=1, publishedTime=Sat Oct 03 13:31:59 CST 2020, publishedTimeString=2019-06-02, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sat Oct 03 13:31:53 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 05:30:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）.doc)])

中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）.doc

下载请点击：

评论区 (5)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1198695, encodeId=6c391198695dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:06:45 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950543, encodeId=b077950543c8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1415461247, createdName=ms9000000285021511, createdTime=Tue Mar 23 23:13:48 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927075, encodeId=3fa892e0751d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef702488722, createdName=12473baem51暂无昵称, createdTime=Thu Feb 25 12:02:51 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894208, encodeId=84db894208cd, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d5428768, createdName=ms9000001185547232, createdTime=Sat Oct 24 22:39:54 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892485, encodeId=0ede89248595, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=202a5331039, createdName=148cc9fam95暂无昵称, createdTime=Fri Oct 16 15:42:43 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2022-03-02 245462683

学习了

32 0
[GetPortalCommentsPageByObjectIdResponse(id=1198695, encodeId=6c391198695dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:06:45 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950543, encodeId=b077950543c8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1415461247, createdName=ms9000000285021511, createdTime=Tue Mar 23 23:13:48 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927075, encodeId=3fa892e0751d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef702488722, createdName=12473baem51暂无昵称, createdTime=Thu Feb 25 12:02:51 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894208, encodeId=84db894208cd, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d5428768, createdName=ms9000001185547232, createdTime=Sat Oct 24 22:39:54 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892485, encodeId=0ede89248595, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=202a5331039, createdName=148cc9fam95暂无昵称, createdTime=Fri Oct 16 15:42:43 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2021-03-23 ms9000000285021511

不错

55 0
[GetPortalCommentsPageByObjectIdResponse(id=1198695, encodeId=6c391198695dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:06:45 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950543, encodeId=b077950543c8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1415461247, createdName=ms9000000285021511, createdTime=Tue Mar 23 23:13:48 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927075, encodeId=3fa892e0751d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef702488722, createdName=12473baem51暂无昵称, createdTime=Thu Feb 25 12:02:51 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894208, encodeId=84db894208cd, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d5428768, createdName=ms9000001185547232, createdTime=Sat Oct 24 22:39:54 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892485, encodeId=0ede89248595, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=202a5331039, createdName=148cc9fam95暂无昵称, createdTime=Fri Oct 16 15:42:43 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2021-02-25 12473baem51暂无昵称

不错

52 0
[GetPortalCommentsPageByObjectIdResponse(id=1198695, encodeId=6c391198695dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:06:45 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950543, encodeId=b077950543c8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1415461247, createdName=ms9000000285021511, createdTime=Tue Mar 23 23:13:48 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927075, encodeId=3fa892e0751d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef702488722, createdName=12473baem51暂无昵称, createdTime=Thu Feb 25 12:02:51 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894208, encodeId=84db894208cd, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d5428768, createdName=ms9000001185547232, createdTime=Sat Oct 24 22:39:54 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892485, encodeId=0ede89248595, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=202a5331039, createdName=148cc9fam95暂无昵称, createdTime=Fri Oct 16 15:42:43 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-24 ms9000001185547232

不错不错

77 0
[GetPortalCommentsPageByObjectIdResponse(id=1198695, encodeId=6c391198695dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df621297957, createdName=245462683, createdTime=Wed Mar 02 13:06:45 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950543, encodeId=b077950543c8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1415461247, createdName=ms9000000285021511, createdTime=Tue Mar 23 23:13:48 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927075, encodeId=3fa892e0751d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef702488722, createdName=12473baem51暂无昵称, createdTime=Thu Feb 25 12:02:51 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894208, encodeId=84db894208cd, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0f0d5428768, createdName=ms9000001185547232, createdTime=Sat Oct 24 22:39:54 CST 2020, time=2020-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892485, encodeId=0ede89248595, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=202a5331039, createdName=148cc9fam95暂无昵称, createdTime=Fri Oct 16 15:42:43 CST 2020, time=2020-10-16, status=1, ipAttribution=)]
2020-10-16 148cc9fam95暂无昵称

不错

72 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

内分泌科指南

中药新药用于糖尿病周围神经病变临床研究技术指导原则（征求意见稿）

相关指南

科室

工具

服务